PRME 250117 2.50P (PRME250117P2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PRME250117P2500

Watchlist

0.05
0.000.00%

15min DelayClose Jan 17 16:00 ET

0.05High0.05Low

Intraday

5D
Daily

News

BMO Capital Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $19
Moomoo NewsJan 15 07:33 ET · Ratings
Prime Medicine's Promising Prospects and Potential Catalysts Justify Buy Rating
TipRanksJan 15 07:25 ET · Ratings
Prime Drink Group Brief: Appointed Audrey Bouchard as Chief Financial Officer, Effective Immediately
MT NewswiresJan 14 10:09 ET
Prime Medicine Advances Gene Editing and Trials
TipRanksJan 13 08:35 ET
Gene Editing Stocks Drop as Intellia Announces Layoffs
Seeking AlphaJan 10 13:29 ET
Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference
Prime MedicineJan 7 00:00 ET

Comments

Trytosaveabit

Nov 22, 2024 19:02

New 13D/A

$Prime Medicine (PRME.US)$ Prime Medicine | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund X, L.P.(11.8%),ARCH Venture Fund X Overage, L.P.(11.8%), etc.
SEC· 17:36

This_Guy

Nov 11, 2024 09:59

$Prime Medicine (PRME.US)$ 👀

Jaguar8

Oct 24, 2024 07:02

NEWS

$Prime Medicine (PRME.US)$
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Cheok

Sep 30, 2024 09:09

$Prime Medicine (PRME.US)$ Break $5!

Jaguar8

Sep 30, 2024 08:48

For me this is the biggest news for the day. Great collab with huge milestones

$Prime Medicine (PRME.US)$